SBRT is an effective approach to local tumor control with limited toxicity in patients with metastatic pancreatic cancer. Given the favorable toxic......READ MORE
Newly approved chemotherapy regimens in the treatment of metastatic pancreatic cancer, such as FOLFIRINOX* and gemcitabine-nab-paclitaxel, have inc......READ MORE
Clinical Study Title:Patterns of Chemotherapy Use in a U.S.-Based Cohort of Patients With Metastatic Pancreatic CancerClinical Study Abstract:Purpo......READ MORE
by Thomas A. Abrams, MD, Andrew Hendifar, MD, MPH, Gauri Varadhachary, MD
The incidence of metastatic pancreatic cancer has increased over the past several decades, and it now ranks as the fourth leading cause of cancer d......READ MORE
by Thomas A. Abrams, MD, Andrew Hendifar, MD, MPH, Gauri Varadhachary, MD
Despite the high mortality rate in metastatic pancreatic cancer, there is optimism surrounding improved outcomes with newly developed treatment reg......READ MORE
Due to improved treatment with newly approved first-line combination treatments in metastatic pancreatic cancer, treatment patterns now demonstrate......READ MORE
